Cardiovascular Therapeutics

译名:心血管治疗学

SCIEJCR Q2中科院3区

1-3

2026

影响因子区间

133天

平台估算

投稿周期

77%

2025

中国作者发文占比

2380 USD;1590 GBP;1880 EUR

费用说明

收费

期刊简介:Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.Subject areas include (but are by no means limited to):Acute coronary syndromeArrhythmiasAtherosclerosisBasic cardiac electrophysiologyCardiac catheterizationCardiac remodelingCoagulation and thrombosisDiabetic cardiovascular diseaseHeart failure (systolic HF, HFrEF, diastolic HF, HFpEF)HyperlipidemiaHypertensionIschemic heart diseaseVascular biologyVentricular assist devicesMolecular cardio-biologyMyocardial regenerationLipoprotein metabolismRadial artery accessPercutaneous coronary interventionTranscatheter aortic and mitral valve replacement.

【译文】心血管治疗学(原名心血管药物评论)是一本同行评审的开放获取期刊,专注于发表关于心血管和临床药理学以及新型心血管疗法临床试验的原创研究和综述文章。鼓励发表关于转化研究、药基因组学和个性化医疗、设备、基因和细胞疗法以及药物流行病学方面的文章。主题领域包括(但不仅限于):急性冠状动脉综合征、心律失常、动脉粥样硬化、基础心脏电生理学、心脏导管术、心脏重塑、凝血和血栓形成、糖尿病心血管疾病、心力衰竭(收缩性HF、HFrEF、舒张性HF、HFpEF)、高脂血症、高血压、缺血性心脏病、血管生物学、心脏辅助装置、分子心脏生物学、心肌再生、脂蛋白代谢、桡动脉通路、经皮冠状动脉介入治疗、经导管主动脉瓣和二尖瓣置换术。

出版社
Wiley
语言
English
学科
医学
ISSN
1755-5914
eISSN
1755-5922
出版频率
季刊
创刊年份
2008
投稿网址
https://mc.manuscriptcentral.com/cdr
最近更新
2026-04-02 18:16:40

指标当前值近三年趋势
JCR分区Q2
暂无
中科院分区3区
暂无
影响因子区间1-3
暂无